Stifel analyst Jonathan Block lowered the firm’s price target on Elanco (ELAN) to $15 from $16 and keeps a Buy rating on the shares. While the quarter and guidance “had a few blemishes,” the firm was “a bit surprised by Elanco’s near-term stock reaction” as it thought the positives outweighed the negatives, the analyst tells investors. With the company pointing to margin expansion in 2026, the firm believes the stock heads higher if management delivers, the analyst added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELAN:
- Cautious Outlook for Elanco Animal Health Amid Lower EPS and EBITDA Projections
- Elanco price target lowered to $19 from $20 at Barclays
- Elanco Animal Health: Promising Growth Amid FX Challenges and Strong Product Pipeline
- Elanco Animal Health Reports 2024 Earnings and 2025 Outlook
- Morning Movers: Home Depot, Keurig Dr Pepper higher after Q4 results